What is the proper dosing for Glipizide (Glibenclamide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION There is no fixed dosage regimen for the management of diabetes mellitus with glipizide or any other hypoglycemic agent. Initial Dose:The recommended starting dose is 5 mg, given before breakfast. Geriatric patients or those with liver disease may be started on 2.5 mg. Titration:Dosage adjustments should ordinarily be in increments of 2. 5–5 mg, as determined by blood glucose response. The maximum recommended once daily dose is 15 mg. Doses above 15 mg should ordinarily be divided and given before meals of adequate caloric content. The maximum recommended total daily dose is 40 mg

The recommended starting dose of glipizide is 5 mg, given before breakfast. The maximum recommended total daily dose is 40 mg.

  • Initial dose: 5 mg for normal patients, 2.5 mg for geriatric patients or those with liver disease
  • Titration: increments of 2.5-5 mg
  • Maximum once daily dose: 15 mg
  • Maximum total daily dose: 40 mg 1

From the Research

Glipizide dosing typically starts at 2.5 mg once daily, taken before breakfast, as indicated in the study comparing sitagliptin with glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency 2. The dose may be adjusted based on blood glucose response, usually increasing by 2.5-5 mg every few days if needed, with a maximum recommended daily dose of 10 mg twice a day, as seen in the study 2. For elderly patients or those with liver impairment, starting at a lower dose of 2.5 mg is recommended. Some key points to consider when prescribing glipizide include:

  • Glipizide is usually taken 30 minutes before meals because it works by stimulating insulin release from the pancreas, which helps lower blood sugar levels.
  • The medication is available in immediate-release tablets (taken once or twice daily) and extended-release formulations (taken once daily).
  • Extended-release tablets should be swallowed whole, not crushed or chewed.
  • Patients should monitor their blood glucose regularly while taking glipizide and be aware of hypoglycemia symptoms such as dizziness, confusion, and sweating.
  • This medication works best when combined with proper diet and exercise as part of a comprehensive diabetes management plan. It's also important to note that glipizide has been compared to other medications, such as sitagliptin, in terms of efficacy and safety, with studies showing that sitagliptin may have a lower risk of hypoglycemia and weight gain compared to glipizide 2. However, the most recent and highest quality study on glipizide dosing is not directly available, but based on the available evidence, the recommended dosing is as mentioned above. Additionally, a study on the effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes found that once-daily dosing results in better adherence and persistence compared to twice-daily dosing 3. But the study that guides the answer the most is the one that is most recent and of the highest quality, which in this case is not directly related to glipizide dosing but rather to the efficacy and safety of glucagon-like peptide 1 receptor agonists, including oral semaglutide, in reducing the incidence of major adverse cardiovascular events and kidney outcomes in individuals with type 2 diabetes 4. However, this study does not provide information on glipizide dosing, and therefore, the answer is based on the study that provides the most relevant information on glipizide dosing 2.

Related Questions

What is the optimal strategy to lower hemoglobin A1c (HbA1c) in a 71-year-old male with hyperglycemia, currently taking metformin (Metformin) 1000 mg twice daily and Jardiance (Empagliflozin) 25 mg daily, without increasing the risk of hypoglycemic episodes?
What is the most appropriate add-on treatment for a 63-year-old woman with Chronic Kidney Disease (CKD), Heart Failure with Reduced Ejection Fraction (HFrEF), Hypertension, Hypothyroidism, and Type 2 Diabetes (T2D) with worsening Glycemic Control (HbA1c increase) and Impaired Renal Function (eGFR 26 mL/min/1.73 m2), currently on Aspirin, Dapagliflozin, Levothyroxine, Metoprolol Succinate, Rosuvastatin, Sacubitril/Valsartan, and Torsemide?
What adjustments should be made to a diabetes medication regimen including sitagliptin, glipizide, and empagliflozin in a patient with impaired renal function?
What is the best add-on medication to metformin (biguanide) and glipizide (sulfonylurea) for a patient with inadequate glycemic control, considering cost?
What is the daily calorie requirement for a 157 cm female?
What is the paramedic report for a patient with a spinal injury transferred from Baptist Community Medical Hospital (BCMH) Emergency Department (ED) to another ED, with vital signs within normal limits (WNL) and pain controlled throughout transport, transported in a position of comfort?
What is the treatment plan for an inferior ramus fracture?
What is the diagnosis and treatment for interstitial pneumonia with a productive cough and mild prominence of interstitial densities on chest x-ray (CXR)?
What is the diagnosis and treatment for interstitial pneumonia with symptoms of productive cough and chest x-ray findings of mild prominence of interstitial densities bilaterally?
What is the appropriate dosing for Glipizide (Glibenclamide)?
What is the diagnosis for an 82-year-old female with a blister on the heel, without redness or swelling?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.